FDA approves Alecensa as first adjuvant treatment for people with ALK-positive early-stage lung cancer

FDA approves Alecensa as first adjuvant treatment for people... MedEdge MEA

Basel- April 2024- Roche announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumour resection f...

Read More
Menu
Categories
How does it work